← Back to Clinical Trials
Recruiting NCT07302984

NCT07302984 Mind-body Skills Groups for War-Related Trauma in Adolescents in Gaza

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07302984
Status Recruiting
Phase
Sponsor The Center for Mind-Body Medicine
Condition Post Traumatic Stress Disorder PTSD
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-12-26
Primary Completion 2026-03

Eligibility & Interventions

Sex All sexes
Min Age 11 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Mind-Body Skills Groups

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-12-26 with a primary completion date of 2026-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if mind-body skills groups can reduce posttraumatic stress disorder and emotional and behavioral problems in war-traumatized adolescents in Gaza. The main questions it aims to answer are: * Do mind-body skills groups reduce posttraumatic stress disorder symptoms in war-traumatized adolescents in Gaza? * Do mind-body skills groups reduce emotional and behavioral problems in war-traumatized adolescents in Gaza? Researchers will compare the results of adolescents who do not attend mind-body skills groups to adolescents who attend mind-body skills groups see if those who attend groups have less posttraumatic stress disorder symptoms and emotional and behavioral problems. Participants will: * Be screened to determine whether they qualify to be in the study * If they qualify, they will attend 5 mind-body skills group sessions (if they are not in the control group) * Fill out research packets before the first session, after the last session, and at 2-month follow-up.

Eligibility Criteria

Inclusion Criteria: * being 11-17 years old and living in Gaza * having experienced a political violence or war-related criterion A stressor * meeting the American Psychiatric Association (APA) Diagnostic and Statistical Manual-(DSM-5-TR) criteria for PTSD according to the screening cut-off score on the Child PTSD Symptom Scale-5 (CPSS-5). Exclusion Criteria: * former psychotherapy or medication to treat mental disorders * having significant cognitive impairment.

Contact & Investigator

Central Contact

Jamil A Atti, PhD

✉ jatti@cmbm.org

📞 +972 (8) 288 8359

Principal Investigator

Julie K. Staples, PhD

STUDY DIRECTOR

The Center for Mind-Body Medicine

Frequently Asked Questions

Who can join the NCT07302984 clinical trial?

This trial is open to participants of all sexes, aged 11 Years or older, up to 17 Years, studying Post Traumatic Stress Disorder PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07302984 currently recruiting?

Yes, NCT07302984 is actively recruiting participants. Contact the research team at jatti@cmbm.org for enrollment information.

Where is the NCT07302984 trial being conducted?

This trial is being conducted at Deir al-Balah, Palestinian Territories.

Who is sponsoring the NCT07302984 clinical trial?

NCT07302984 is sponsored by The Center for Mind-Body Medicine. The principal investigator is Julie K. Staples, PhD at The Center for Mind-Body Medicine. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology